Low-molecular Weight Heparin Induces In Vitro Trophoblast Invasiveness: Role of Matrix Metalloproteinases and Tissue Inhibitors

Placenta

Volumn 28, Issue 4, 2007, Pages 298-304

  Di Simone, N ^a   Di Nicuolo, F ^a   Sanguinetti, M ^a   Ferrazzani, S ^a   D'Alessio, M C ^a   Castellani, R ^a   Bompiani, A ^a   Caruso, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Heparin; Metalloproteinase; Pregnancy; Trophoblast

Indexed keywords

GELATINASE A; GELATINASE B; LOW MOLECULAR WEIGHT HEPARIN; MATRIGEL; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL INVASION; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TROPHOBLAST;

ANTICOAGULANTS; CELL MOVEMENT; CHORIOCARCINOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HEPARIN, LOW-MOLECULAR-WEIGHT; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 33947725054     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.04.001     Document Type: Article

References (26)

1. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174 (1996) 1584-1589
2. Rai R., Cohen H., Dave M., and Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314 (1997) 253-257
3. Salafia C.M., and Cowchock F.S. Placental pathology and antiphospholipid syndrome: a descriptive study. Am J Perinatol 14 (1997) 435-441
4. Sebire N.J., Backos M., El Gaddal S., Goldin R.D., and Regan L. Placental pathology antiphospholipid antibodies and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 101 (2003) 258-263
5. Sebire N.J., Fox H., Backos M., Rai R., Paterson C., and Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 17 (2002) 1067-1071
6. Di Simone N., Meroni P.L., Del Papa N., Raschi E., Caliandro D., De Carolis S., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta-2-glycoprotein I. Arthritis Rheum 43 (2000) 140-150
7. Guerin J., Sheng Y., Reddel S., Iverson G.M., Chapman M.G., and Krilis S.A. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem 277 (2002) 2644-2649
8. Di Simone N., Caliandro D., Castellani R., Ferrazzani S., De Carolis S., and Caruso A. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 14 (1999) 489-495
9. Isaka K., Usuda S., Ito H., Sagawa Y., Nakamura H., Nishi H., et al. Expression and activation of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta 24 (2003) 53-64
10. Tarrade A., Lai Kuen R., Malassinè A., Tricottet V., Blain P., Vidaud M., et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest 81 (2001) 1199-1211
11. Di Simone N., Maggiano N., Caliandro D., Riccardi P., Evangelista A., Carducci B., et al. Homocysteine induces trophoblast cell death with apoptotic features. Biol Reprod 69 (2003) 1129-1134
12. Peirson S.N., Butler J.N., and Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acid Res 31 (2003) e73
13. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid 29 (2001) e45
14. Meijerink J., Mandingers C., van de Locht L., Tonnissen E., Goodsaid F., and Raemaekers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn 3 (2001) 55-61
15. Librach C.L., Werb Z., Fitzgerald M.L., Chiu K., Corwin N.M., Esteves R.A., et al. 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 113 (1991) 437-449
16. Shimonovitz S., Hurwitz A., Dushnik M., Anteby E., Geva-Eldar, and Yagel S. Development regulation of the expression of 72 and 92 kDa type collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol 171 (1994) 832-838
17. Staun-Ram E., Goldman S., Gabarin D., and Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2 (2004) 59-72
18. Bai X.S., Wang Y.L., Qin L., Xiao Z.J., Herva R., and Piao S.Y. Dynamic expression of matrix metalloproteinase (MMP-2, -9 and -14) and tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Reproduction 129 (2005) 103-113
19. Moriyama T., Otani T., and Maruo T. Expression of adrenomedullin by human placental cytotrophoblasts and choriocarcinoma Jar cells. J Clin Endocrinol Metab 86 (2001) 3958-3961
20. Bamberger A.M., Ezzat S., Cao B., Wong M., Parker K.L., Sculte H.M., et al. Expression of steroidogenic factor-1 (SF-1) mRNA and protein in the human placenta. Mol Hum Reprod 2 (1996) 457-461
21. Stetler-Stevenson W.G., Krutzsch H.C., and Liotta L.A. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264 (1989) 17374-17378
22. Fiedler K., and Wurfel W. Effectivity of heparin in assisted reproduction. Eur J Med Res 9 (2004) 207-214
23. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69 (2006) 562-573
24. Ongusaha P.P., Kwak J.C., Zwible A.J., Macip S., Higashiyama S., Taniguchi N., et al. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res 64 (2004) 5283-5290
25. Mousa S.A. Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix-degrading enzyme aggrecanase: structure-function relationship. J Cell Biochem 95 (2005) 95-98
26. Sawicki G., Salas E., Murat J., Miszta-Lane H., and Radomski M.W. Release of gelatinase A during platelet activation mediated aggregation. Nature 386 (1997) 616-619